Company Directory / Pharmaceuticals

Antibiotice logo

PublicFor profitPharmaceuticalsIași, România, Romania

Antibiotice

Antibiotice is a pharmaceutical product manufacturing firm.

Founded
1955
71 years ago
Staff
1001-5000
601 on LinkedIn
Followers
21k
on LinkedIn
Funding
$25M
as listed, USD

Starting with penicillin, our first product manufactured in 1955, our company produced hundreds of pharmaceutical substances. Today, Antibiotice is one of the most important Romanian producers of generic drugs. What kind of pharmaceutical products do we produce? Antibiotice develops and produces generic drugs for human use (160 products), veterinary drugs and the active ingredient Nystatin. Our generic drugs are mainly intended to patients with infectious diseases, but also for cardiovascular, dermatological,… Read all

Starting with penicillin, our first product manufactured in 1955, our company produced hundreds of pharmaceutical substances. Today, Antibiotice is one of the most important Romanian producers of generic drugs. What kind of pharmaceutical products do we produce? Antibiotice develops and produces generic drugs for human use (160 products), veterinary drugs and the active ingredient Nystatin. Our generic drugs are mainly intended to patients with infectious diseases, but also for cardiovascular, dermatological, digestive and central nervous system related pathologies. Domestic and international market We have been present with pharmaceutical products and Nystatin API in Romania and other over 70 countries around the world. In terms of Nystatin active ingredient production, Antibiotice ranks first worldwide among the pharmaceutical manufacturers. In Romania we continue to be the main manufacturer of antiinfective generic drugs, a manufacturer with competitive medicines and affordable prices. Our medicines are delivered in hospitals – especially the antiinfectives – contributing overall to significant savings for the Romanian healthcare system. Quality standards Our continuous development and expansion on international markets were possible through consistent investments and implementation of internationally recognized quality standards:: • Good Manufacturing Practice (EU-GMP) • Certificate of compliance with European Pharmacopoeia (COS) • Food and Drug Administration authorization (FDA)

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

1001-5000 people: larger than 97% of companies with a size listed. 601 people list it on LinkedIn.

Age

195519002026

71 years old.

Reach

Website ranked #3,877,224 in the world for traffic, about 3k visits a month. 20,877 followers on LinkedIn.

What it does

PharmaceuticalPharmaceutical

What it is known for

pharmaceuticalpharmaceutical manufacturingnystatintherapeutic areasregulatory approvalshealthcare affordabilitymicrobial biosynthesisproduct developmentmedical productsexporteu-gmpinvestment in researchantifungal agent exportresearch centervaccine and drug developmentactive pharmaceutical ingredients

What its website runs on

BrevoMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeMicrosoft 365Microsoft 365 Apps & ServicesApacheHREF LangFacebookOpenSSLGoogle Tag ManagerApache HTTP ServerbxSliderPriority HintsContact Form 7MailChimpPrimeNG

Funding, as listed

$25M raised in total

  • Rounds1
  • LatestPost ipo debt, Nov 2023
  • Latest amountUSD 86,803,500
  • Investors1, 1 leading

What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.

Annual revenue$158M
NAICS325412

Every detail we hold

Everything the source datasets list about Antibiotice, field by field. Contact details are held but never shown.

The company

Name
Antibiotice
Type
For profit
Status
Public
Founded
1955
Industry
Pharmaceuticals
Categories
Pharmaceutical
Specialities
Pharmaceutical

Where

City
Iași
Region
România
Country
Romania
Markets
European Union (EU), Europe, Middle East, and Africa (EMEA)

Size and reach

Staff band
1001-5000
People on LinkedIn
601
LinkedIn followers
20,877
Web traffic rank
#3,877,224
Monthly web visits
2,964
Annual revenue
$158M

Funding, as listed

Total
$25,000,000 USD
Rounds
1
Latest round
Post ipo debt
Latest round date
Nov 2023
Latest amount
86,803,500 USD
Investors
1
Lead investors
1
Listing status
public

Classification

NAICS
325412
SIC
2834
Keywords
16 listed, shown above
Technologies
18 detected, shown above

About this record

Sources
Crunchbase, LinkedIn, Apollo
Last imported
Sept 2026

Growth, as the source summarises it

Antibiotice may be growing as the company has shown a significant increase in net profit, which is a strong indicator of financial health and potential expansion. Specifically, the firm's net profit grew by 58% in 2023, reflecting a robust performance in the pharmaceutical industry. This substantial growth in profitability suggests that Antibiotice has been successful in its operations and financial management, which could be attributed to factors such as efficient production, effective cost control, or increased demand for its pharmaceutical products.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Pharmaceuticals in Romania.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 15,387 companies in Romania and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.